Abstract
Background
Rapid identification of antimicrobial resistance markers has the potential to help targeting antimicrobial therapy and enhance efforts for antibiotic stewardship. However, limited data are available to correlate phenotypic and genotypic results for some of these platforms in positive blood cultures (BC). Here, we aimed to evaluate the ability of the Verigene® (VG) Blood Culture System to predict phenotypic susceptibility patterns with the detection of the genes encoding the CTX-M in Enterobacteriaceae and MecA in S. aureus (SA) in a large dataset.
Methods
Phenotypic susceptibility and VG results were retrospectively collected between August 2017 and December 2018 from 12 hospitals in Houston, TX. VG testing was performed on only the first isolate was considered in persistent positive BCs. The VG report of the presence of blaCTX-M or mecA was correlated with phenotypic susceptibility to ceftriaxone (CTO) (E. coli [EC] and Klebsiella spp.[KL]) or oxacillin (SA), respectively.
Results
We identified a total of 5,937 VG results. The final analysis was performed on 2,356 cases where EC, KL or SA was identified. Isolates detected KPC and NDM by VG were excluded. 30 EC/KL were missed by VG in polymicrobial bacteremia. 7 polymicrobial positive BCs with coagulase-negative staphyloccocci were mislabeled as MecA positive MSSA. Among isolated detected by VG, there were the high sensitivity and specificity of CTX-M to identify CTO resistance (97.2% and 99.7% in EC and 91.4% and 99.2% in KL). For SA, the sensitivity and specificity of mecA were 100% and 99.6% to identify oxacillin resistance. 2 isolates with mecA positive by VG were reported as oxacillin-suscpetible.
Conclusion
Our results revealed that there is a high correlation between VG and phenotype. For SA, discrepancies between genotype and phenotype seem to be influenced by the presence of other organisms in the sample. Genotypic information seems reliable and should guide targeted therapy in bloodstream infections.
Disclosures
All authors: No reported disclosures.
Comparison of the VersaTREK blood culture system against the Bactec9240 system in patients with suspected bloodstream infections
